Interestingly, breast tumor samples with somatic damaging (nonsense, frameshift or missense) mutations in BRCA1 or BRCA2 genes showed a higher expression of Signature-3 score than tumors with BRCA1/2 wt genes (Supplementary Table S3). The gene discussed is BRCA2; the disease is breast neoplasm.